Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 175 of 499 entries
View as:

Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide

Phase: N/A Priority: Normal
NCT ID: NCT00632853 Org: User:
Start: 03/31/08 End: - Due: -

Capecitabine in Treating Patients With Malignant Mesothelioma

Phase: N/A Priority: Normal
NCT ID: NCT00004183 Org: User:
Start: 11/30/00 End: 01/31/06 Due: 01/31/07

Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00003170 Org: User:
Start: 02/28/98 End: 06/30/03 Due: 06/30/04

Liposomal SN-38 in Treating Patients With Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00311610 Org: User:
Start: 01/31/06 End: 06/30/10 Due: 06/30/11

Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung

Phase: N/A Priority: Normal
NCT ID: NCT00005610 Org: User:
Start: 09/30/00 End: 06/30/06 Due: 06/30/07

Gemcitabine and Carboplatin With or Without AZD2171 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00326599 Org: User:
Start: 06/30/07 End: 02/28/10 Due: 02/28/11

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00032032 Org: User:
Start: 05/31/02 End: 01/31/10 Due: 01/31/11

Surgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00881361 Org: User:
Start: 07/31/09 End: 04/15/23 Due: 04/15/24

Vinorelbine in Treating Older Women With Stage IV Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00022152 Org: User:
Start: 11/30/01 End: 08/31/07 Due: 08/31/08

Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects

Phase: N/A Priority: Normal
NCT ID: NCT04242095 Org: User:
Start: 03/12/20 End: 10/01/26 Due: 10/01/27

Testing the Combination of Two Approved Drugs and One Experimental Drug in Patients With Relapsed or Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT06232044 Org: User:
Start: 04/23/25 End: 08/01/30 Due: 08/01/31

Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations

Phase: N/A Priority: Normal
NCT ID: NCT03609216 Org: User:
Start: 12/10/18 End: 02/01/29 Due: 02/01/30

Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma

Phase: N/A Priority: Normal
NCT ID: NCT05647265 Org: User:
Start: 11/27/24 End: 12/15/26 Due: 12/15/27

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06661720 Org: User:
Start: 03/14/25 End: 11/30/37 Due: 11/30/38

High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06992427 Org: User:
Start: 06/05/25 End: 04/15/31 Due: 04/15/32

Testing Low Dose Tamoxifen for Invasive Breast Cancer, the (LoTam) Trial

Phase: N/A Priority: Normal
NCT ID: NCT06671912 Org: User:
Start: 02/19/25 End: 11/30/31 Due: 11/30/32

Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06632327 Org: User:
Start: 12/11/24 End: 04/30/30 Due: 04/30/31

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

Phase: N/A Priority: Normal
NCT ID: NCT06632977 Org: User:
Start: 02/06/25 End: 10/11/34 Due: 10/11/35

Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00553462 Org: User:
Start: 03/31/08 End: 06/15/17 Due: 06/15/18

Magnesium Oxide in Treating Postmenopausal Women With Hot Flashes and a History of Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01439945 Org: User:
Start: 09/30/11 End: 08/31/13 Due: 08/31/14

Acitretin in Preventing Skin Cancers in Patients With Previously Treated Skin Cancers Who Have Undergone Organ Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT00003611 Org: User:
Start: 05/31/00 End: 06/30/03 Due: 06/30/04

Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01005368 Org: User:
Start: 10/31/09 End: 04/01/22 Due: 04/01/23

Celecoxib in Treating Women With Metastatic or Recurrent Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00045591 Org: User:
Start: 02/28/03 End: 01/31/10 Due: 01/31/11

Combination Chemotherapy With or Without Ganitumab in Treating Patients With Previously Untreated Metastatic Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01473303 Org: User:
Start: 08/31/12 End: - Due: -

Genetic Study of Familial Factors in Patients With Colon Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00055848 Org: User:
Start: 12/31/01 End: 10/31/10 Due: 10/31/11